Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 39 (PPIAP39) is a human processed pseudogene related to the functional PPIA gene, which encodes cyclophilin A, a peptidyl-prolyl cis-trans isomerase enzyme. PPIAP39 does not code for a functional protein and is not considered a therapeutic target or druggable entity. While its parent gene (PPIA) plays roles in protein folding, signal transduction, inflammation, and cancer, there is no evidence that PPIAP39 has independent biological function, relevance in disease, or application in drug development or biomarker discovery. Its annotation as "pseudogene" denotes loss of protein-coding potential, often via mutation or truncation, and its entries are primarily for genomic reference.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 39 (PPIAP39).